BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21914581)

  • 1. Kimura's disease treated with suplatast tosilate and loratadine.
    Ueda T; Arai S; Amoh Y; Katsuoka K
    Eur J Dermatol; 2011; 21(6):1020-1. PubMed ID: 21914581
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiolymphoid hyperplasia with eosinophilia: successful treatment with the antiallergic agent suplatast tosilate.
    Harada K; Kambe Y; Takeda H; Nakano H; Hanada K
    Dermatology; 2004; 208(2):176-7. PubMed ID: 15057015
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
    Yoshihara S; Fukuda H; Arisaka O
    Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiolymphoid hyperplasia with eosinophilia on the leg successfully treated with T-helper cell 2 cytokine inhibitor suplatast tosilate.
    Bito T; Kabashima R; Sugita K; Tokura Y
    J Dermatol; 2011 Mar; 38(3):300-2. PubMed ID: 21342240
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
    Kimata H
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kimura's disease associated with bronchial asthma presenting eosinophilia and hyperimmunoglobulinemia E which were attenuated by suplatast tosilate (IPD-1151T).
    Tsukagoshi H; Nagashima M; Horie T; Oyama T; Yoshii A; Sato T; Iizuka K; Dobashi K; Mori M
    Intern Med; 1998 Dec; 37(12):1064-7. PubMed ID: 9932643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case report of eosinophilic cystitis treated with oral suplatast tosilate].
    Kuramoto T; Senzaki H; Inagaki T
    Hinyokika Kiyo; 2014 Sep; 60(9):447-50. PubMed ID: 25293800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cough-variant asthma successfully treated with suplatast tosilate].
    Fujimori K; Suzuki E; Arakawa M
    Arerugi; 1998 Jul; 47(7):694-7. PubMed ID: 9780445
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-inflammatory effect of suplatast tosilate on mild asthma.
    Sano Y; Miyamoto T; Makino S
    Chest; 1997 Sep; 112(3):862-3. PubMed ID: 9315837
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of eosinophilic cystitis that was treated with oral suplatast tosilate (IPD-1151T)].
    Watanabe M; Yamaguchi K; Yamanishi T; Kamai T; Yoshida K
    Hinyokika Kiyo; 2009 Nov; 55(11):715-9. PubMed ID: 19946192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic eosinophilic pneumonia successfully treated with suplatast tosilate].
    Hamada H; Sakatani M; Nishioka M; Akira M; Yamamoto S; Ueda E; Okano Y; Nakamura Y; Sone S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):692-7. PubMed ID: 9294307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of non-episodic angioedema associated with eosinophilia with suplatast tosilate, an anti-allergic selective Th2 cytokine inhibitor.
    Hashizume H; Umayahara T
    Eur J Dermatol; 2014; 24(2):250-2. PubMed ID: 24723649
    [No Abstract]   [Full Text] [Related]  

  • 13. Suplatast tosilate for treating cutaneous mastocytosis.
    Yasudo H; Ando T; Hiwatari M; Oka A
    Pediatr Dermatol; 2015; 32(3):e118-9. PubMed ID: 25779849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
    Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of recurrent cutaneous eosinophilic vasculitis: successful adjuvant therapy with suplatast tosilate.
    Sakuma-Oyama Y; Nishibu A; Oyama N; Saito M; Nakamura K; Kaneko F
    Br J Dermatol; 2003 Oct; 149(4):901-3. PubMed ID: 14616398
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
    Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
    Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemphigoid nodularis associated with psoriatic erythroderma: successful treatment with suplatast tosilate.
    Teraki Y; Fukuda T
    Br J Dermatol; 2008 Feb; 158(2):424-6. PubMed ID: 18047503
    [No Abstract]   [Full Text] [Related]  

  • 18. [Successful treatment of chronic eosinophilic pneumonia with suplatast tosilate].
    Kusumoto H; Mizuno K; Yonemaru M; Nakano M; Ichinose Y; Toyama K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 May; 35(5):550-4. PubMed ID: 9234634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
    Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
    J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suplatast tosilate dimethylsulfonium treatment for steroid-dependent nephrotic syndrome.
    Ohtomo Y; Fujinaga S; Hattori M
    Pediatr Int; 2005 Apr; 47(2):230-1. PubMed ID: 15771702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.